Kohlberg to acquire majority stake in Worldwide Clinical Trials from TJC.

Kohlberg, a private equity firm, agreed to acquire majority stake in Worldwide Clinical Trials, a full service contract research organization, from TJC, a private equity firm focused on leveraged buyout and management buyout investments. Financial terms were not disclosed. “Over the past few years, we’ve been on a growth journey at Worldwide driven by a deliberate strategy centered on deep scientific expertise and aligned with industry trends and customer needs – one that sets us apart from others in our space. Our team members and their trusted customer relationships are the driving force behind our success, and I thank our partners at TJC for their many years of support helping us build to where we are today. We are thrilled to team up with Kohlberg, who brings us considerable depth of experience across the full continuum of outsourced pharma services, and I look forward to the next phase of our growth journey and continuing to help our customers bring new life-changing medications and treatments to patients around the world," Peter Benton, Worldwide President and Co-CEO.